Peptide News Digest

#Mechanism

2 stories

Research · View digest

BPC-157 Multifunctionality Comment Paper in Pharmaceuticals: Angiogenesis and Nitric Oxide Pathway Discussion Continues Ahead of PCAC

A 2026 Pharmaceuticals (MDPI) comment paper responds to the Józwiak et al. 2025 multifunctionality review of BPC-157, focusing on the peptide's role in targeting angiogenesis and modulating nitric oxide's cytotoxic versus protective actions. The response paper argues BPC-157's clinical claim breadth — wound healing, GI ulcer repair, tendon healing, neuroprotection — derives from a single biochemical hub: the peptide's interaction with vascular endothelial growth factor receptor 2 (VEGFR2) signaling and the NO/cGMP axis. The discussion lands as BPC-157 sits on the FDA's bulks-list review track for the July 23-24 PCAC meeting, with the underlying mechanistic literature still anchored on a small number of research groups. The Pharmaceuticals exchange illustrates the pre-clinical evidence gap that PCAC will weigh against the wide compounding-pharmacy demand signal.

Research · View digest

Nature (May 6): Brain Reward Circuit Inhibited by Next-Generation Weight-Loss Drugs — UVA Team Shows Small-Molecule GLP-1s Engage Central Amygdala Glp1r+ Neurons

A Nature paper published May 6 from a University of Virginia team developed humanized GLP1R mouse models to investigate how small-molecule GLP1R agonists — including orforglipron (Foundayo) — regulate feeding behavior. Beyond canonical hypothalamic and hindbrain networks that control metabolic homeostasis, the team showed these oral compounds recruit a discrete population of Glp1r-expressing neurons in the central amygdala and selectively suppress consumption of palatable foods by reducing dopamine release in the nucleus accumbens — a parallel hedonic-feeding circuit distinct from the homeostatic mechanism that drives most GLP-1 weight loss. The work explains why patients on small-molecule oral GLP-1s often report reduced food cravings and pleasure-driven eating, and identifies a neural circuit with implications for substance-use disorder and binge eating beyond obesity.